US Stock MarketDetailed Quotes

VTVT vTv Therapeutics

Watchlist
  • 28.9900
  • -0.0200-0.07%
Trading May 23 12:16 ET
70.53MMarket Cap-3324P/E (TTM)

vTv Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-41.99%-7.34M
-19.09%-19.08M
57.65%-2.91M
45.24%-4.83M
-973.51%-6.17M
-405.97%-5.17M
17.02%-16.02M
-7.22%-6.88M
-145.60%-8.83M
117.66%706K
Net income from continuing operations
-4.24%-6.02M
-3.56%-25.97M
27.08%-4.44M
-56.18%-8.54M
-76.26%-7.21M
38.73%-5.77M
-41.41%-25.07M
35.78%-6.09M
-273.24%-5.47M
-386.44%-4.09M
Operating gains losses
55.88%371K
-284.25%-3.64M
-345.38%-3.23M
-205.25%-341K
-471.70%-303K
148.37%238K
41.21%-946K
27.35%-725K
124.40%324K
94.31%-53K
Depreciation and amortization
0.00%22K
-2.17%90K
0.00%23K
-8.33%22K
4.55%23K
-4.35%22K
3.37%92K
4.55%23K
9.09%24K
0.00%22K
Other non cash items
----
163.20%213K
--0
--0
--0
--213K
---337K
---146K
---141K
----
Change In working capital
-201.74%-1.93M
-18.40%4.39M
256.83%1.29M
98.63%-48K
-72.27%1.26M
-63.27%1.9M
15,285.71%5.39M
-122.27%-820K
-47.10%-3.5M
2,206.60%4.54M
-Change in receivables
-608.09%-879K
161.21%71K
12.07%-102K
--0
--0
--173K
-214.85%-116K
-113.32%-116K
102.16%20K
-1,100.00%-20K
-Change in prepaid assets
-31.55%473K
458.06%1.44M
161.94%778K
3.52%-548K
-24.24%522K
-5.60%691K
51.97%-403K
-166.10%-1.26M
54.19%-568K
106.91%689K
-Change in payables and accrued expense
-246.41%-1.51M
442.17%2.93M
17.47%659K
116.93%500K
125.50%738K
-76.70%1.03M
-146.83%-856K
-83.21%561K
-1,292.92%-2.95M
-2,143.41%-2.89M
-Change in other current assets
--28K
--105K
----
----
----
--0
--0
----
----
----
-Change in other current liabilities
---40K
---154K
----
----
----
--0
--0
----
----
----
-Change in other working capital
----
----
----
----
----
----
772.64%6.76M
0.00%-9K
--0
----
Cash from discontinued investing activities
Operating cash flow
-41.99%-7.34M
-19.09%-19.08M
57.65%-2.91M
45.24%-4.83M
-973.51%-6.17M
-405.97%-5.17M
17.02%-16.02M
-7.22%-6.88M
-145.60%-8.83M
117.66%706K
Investing cash flow
Cash flow from continuing investing activities
21,071.43%4.4M
4.4M
0
-21K
0
0
Net PPE purchase and sale
----
--0
--0
--0
----
----
---21K
--0
--0
----
Net business purchase and sale
----
--4.4M
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
21,071.43%4.4M
--4.4M
--0
----
----
---21K
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
324.73%50.14M
-18.69%12M
-107.69%-282K
-92.50%473K
0
4,711.72%11.81M
-45.31%14.75M
1,278.57%3.67M
-48.86%6.3M
-21.05%5.04M
Net issuance payments of debt
-101.62%-191K
-3.13%-33K
15.32%-282K
-15.08%473K
---12.03M
4,711.72%11.81M
-118.60%-32K
12.37%-333K
-12.42%557K
--0
Net common stock issuance
--50.34M
-18.64%12.03M
--0
--0
--12.03M
--0
-44.74%14.79M
1,408.67%9.75M
--0
----
Proceeds from stock option exercised by employees
----
--0
--0
----
----
----
--0
---5.75M
----
----
Cash from discontinued financing activities
Financing cash flow
324.73%50.14M
-18.69%12M
-107.69%-282K
-92.50%473K
--0
4,711.72%11.81M
-45.31%14.75M
1,278.57%3.67M
-48.86%6.3M
-21.05%5.04M
Net cash flow
Beginning cash position
-22.10%9.45M
-9.61%12.13M
-46.29%8.24M
-29.47%12.6M
54.61%18.77M
-9.61%12.13M
133.43%13.42M
-21.60%15.34M
64.86%17.86M
43.66%12.14M
Current changes in cash
544.71%42.81M
-107.91%-2.68M
137.60%1.21M
-72.78%-4.36M
-207.72%-6.17M
619.97%6.64M
-116.81%-1.29M
47.76%-3.21M
-128.91%-2.52M
139.94%5.73M
End cash Position
178.46%52.26M
-22.10%9.45M
-22.10%9.45M
-46.29%8.24M
-29.47%12.6M
54.61%18.77M
-9.61%12.13M
-9.61%12.13M
-21.60%15.34M
64.86%17.86M
Free cash flow
-41.99%-7.34M
-18.94%-19.08M
57.65%-2.91M
45.24%-4.83M
-1,000.29%-6.17M
-405.97%-5.17M
16.91%-16.04M
-7.22%-6.88M
-145.60%-8.83M
117.13%685K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -41.99%-7.34M-19.09%-19.08M57.65%-2.91M45.24%-4.83M-973.51%-6.17M-405.97%-5.17M17.02%-16.02M-7.22%-6.88M-145.60%-8.83M117.66%706K
Net income from continuing operations -4.24%-6.02M-3.56%-25.97M27.08%-4.44M-56.18%-8.54M-76.26%-7.21M38.73%-5.77M-41.41%-25.07M35.78%-6.09M-273.24%-5.47M-386.44%-4.09M
Operating gains losses 55.88%371K-284.25%-3.64M-345.38%-3.23M-205.25%-341K-471.70%-303K148.37%238K41.21%-946K27.35%-725K124.40%324K94.31%-53K
Depreciation and amortization 0.00%22K-2.17%90K0.00%23K-8.33%22K4.55%23K-4.35%22K3.37%92K4.55%23K9.09%24K0.00%22K
Other non cash items ----163.20%213K--0--0--0--213K---337K---146K---141K----
Change In working capital -201.74%-1.93M-18.40%4.39M256.83%1.29M98.63%-48K-72.27%1.26M-63.27%1.9M15,285.71%5.39M-122.27%-820K-47.10%-3.5M2,206.60%4.54M
-Change in receivables -608.09%-879K161.21%71K12.07%-102K--0--0--173K-214.85%-116K-113.32%-116K102.16%20K-1,100.00%-20K
-Change in prepaid assets -31.55%473K458.06%1.44M161.94%778K3.52%-548K-24.24%522K-5.60%691K51.97%-403K-166.10%-1.26M54.19%-568K106.91%689K
-Change in payables and accrued expense -246.41%-1.51M442.17%2.93M17.47%659K116.93%500K125.50%738K-76.70%1.03M-146.83%-856K-83.21%561K-1,292.92%-2.95M-2,143.41%-2.89M
-Change in other current assets --28K--105K--------------0--0------------
-Change in other current liabilities ---40K---154K--------------0--0------------
-Change in other working capital ------------------------772.64%6.76M0.00%-9K--0----
Cash from discontinued investing activities
Operating cash flow -41.99%-7.34M-19.09%-19.08M57.65%-2.91M45.24%-4.83M-973.51%-6.17M-405.97%-5.17M17.02%-16.02M-7.22%-6.88M-145.60%-8.83M117.66%706K
Investing cash flow
Cash flow from continuing investing activities 21,071.43%4.4M4.4M0-21K00
Net PPE purchase and sale ------0--0--0-----------21K--0--0----
Net business purchase and sale ------4.4M------------------0------------
Cash from discontinued investing activities
Investing cash flow ----21,071.43%4.4M--4.4M--0-----------21K--0--0----
Financing cash flow
Cash flow from continuing financing activities 324.73%50.14M-18.69%12M-107.69%-282K-92.50%473K04,711.72%11.81M-45.31%14.75M1,278.57%3.67M-48.86%6.3M-21.05%5.04M
Net issuance payments of debt -101.62%-191K-3.13%-33K15.32%-282K-15.08%473K---12.03M4,711.72%11.81M-118.60%-32K12.37%-333K-12.42%557K--0
Net common stock issuance --50.34M-18.64%12.03M--0--0--12.03M--0-44.74%14.79M1,408.67%9.75M--0----
Proceeds from stock option exercised by employees ------0--0--------------0---5.75M--------
Cash from discontinued financing activities
Financing cash flow 324.73%50.14M-18.69%12M-107.69%-282K-92.50%473K--04,711.72%11.81M-45.31%14.75M1,278.57%3.67M-48.86%6.3M-21.05%5.04M
Net cash flow
Beginning cash position -22.10%9.45M-9.61%12.13M-46.29%8.24M-29.47%12.6M54.61%18.77M-9.61%12.13M133.43%13.42M-21.60%15.34M64.86%17.86M43.66%12.14M
Current changes in cash 544.71%42.81M-107.91%-2.68M137.60%1.21M-72.78%-4.36M-207.72%-6.17M619.97%6.64M-116.81%-1.29M47.76%-3.21M-128.91%-2.52M139.94%5.73M
End cash Position 178.46%52.26M-22.10%9.45M-22.10%9.45M-46.29%8.24M-29.47%12.6M54.61%18.77M-9.61%12.13M-9.61%12.13M-21.60%15.34M64.86%17.86M
Free cash flow -41.99%-7.34M-18.94%-19.08M57.65%-2.91M45.24%-4.83M-1,000.29%-6.17M-405.97%-5.17M16.91%-16.04M-7.22%-6.88M-145.60%-8.83M117.13%685K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg